SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Traders are reacting to the Federal Reserve's unanimous decision to raise interest rates, with many discussing the hawkish tone of the central bank's projections and the potential for further hikes. Market participants are debating the impact of these developments, often highlighting the friction between the Fed's policy actions and political demands for lower borrowing costs amid ongoing inflationary pressures.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Traders are intensely focused on the Federal Reserve's unanimous decision to raise interest rates and the subsequent updated dot plot, which signals further tightening ahead. Market sentiment remains volatile as participants debate the impact of the hike on high-growth assets and the broader economy, often highlighting the friction between the Fed's policy actions and political demands for lower rates.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike shares are trending as the company faces ongoing pressure from weak sales, concerns over its long-term turnaround strategy, and a recent removal from the S&P 100. The community remains deeply divided, with some investors viewing current levels as a generational buying opportunity while many others criticize the management's direction and favor continued shorting.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is trending due to a sharp sell-off following a second fiscal 2026 guidance cut driven by persistent manufacturing ramp-up delays at its Houston facility. While the stock saw a dramatic rebound from its after-hours lows, retail investors remain divided between those viewing the pullback as a buying opportunity given the company's strong project backlog and those concerned about ongoing execution issues and management's credibility.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

Generac is trending following a supply agreement with Amazon for backup power generators at data centers, with traders debating the deal's scale and potential for further hyperscaler contracts. While some investors remain cautious about residential demand and valuation, others view the expansion into industrial infrastructure as a significant growth catalyst.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

The community is currently debating whether a reported call for an AI development "slowdown" by industry leaders represents a legitimate concern, market manipulation, or an attempt to create regulatory barriers to entry. While some traders view this as a potential catalyst for a pullback, many others dismiss the news as noise and intend to buy the dip, arguing that infrastructure demand for AI remains unaffected.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVA is trending as retail traders grow increasingly bullish on the company's clear path to profitability and commercial execution of its Amtagvi therapy, with anticipation building for upcoming NSCLC clinical trial data. Investors remain focused on potential institutional accumulation and the expectation of long-term value as the company expands its platform across new cancer indications.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

The community is primarily focused on the company's failure to place in the "Gauntlet 2" drone competition, a development that many traders view as a significant setback for the company's competitive standing and near-term revenue prospects. While some investors maintain a bullish outlook on the company's defense-related drone and boat portfolio, others are increasingly critical of management's perceived lack of transparency and failure to deliver on promised contracts.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Lennar is trending following fiscal Q3 earnings that missed analyst expectations on both earnings and revenue, while the company also reduced its full-year delivery guidance due to persistent pressure from high mortgage rates and affordability challenges. While some traders highlight the company's strong balance sheet and operational efficiency, many are focusing on the broader, unfavorable housing environment and potential further downside in the stock price.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders debate the impact of rising 10-year Treasury yields, which have recently breached the 5% level, and the likelihood of a Federal Reserve rate hike. The community is split between bearish sentiment over the impact of persistent inflation and fiscal debt on bond prices, and those speculating on a potential market reversal as institutional interest in long-duration assets grows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ONC holy hell, zbeigene is still in business? And trading at a 60 p/e?

Can’t short this and other certain biotech stocks enough @Shortseller 

$GSK bought $NUVL for a reason.  BeOne? beigene? Be Gone 😂 s

StockTwits for iOS

BeOne Medicines Ltd - ADR

Glaxosmithkline plc - ADR

Nuvalent Inc - Ordinary Shares - Class A

 holy hell, zbeigene is still in business? And trading at a 60 p/e?

Can’t short this and other certain biotech stocks enough 

 for a reason.  BeOne? beigene? Be Gone 😂 s

CMWYW

@JuggernautRaider @Shortseller one of the best cancer pipelines in the world. 6 billion in sales. Sonrotoclax just approved. Breast cancer and tremendous data on degrader. Short at your own risk.

Max Power

Rainer Zufall

 one of the best cancer pipelines in the world. 6 billion in sales. Sonrotoclax just approved. Breast cancer and tremendous data on degrader. Short at your own risk.